Independent research teams focusing on high-quality molecular profiling studies, centering on the impact of immune-based treatments for cancer patients, may have a funding source available. That is, financial support worth up to $200,000 in both reagents and money via the Oncomine Clinical Research Grant program now available to support research projects in oncology. Recently, Thermo Fisher Scientific announced submissions are open for interested researchers. Grant proposals are due now through July 16, 2021. Thermo Fisher Scientific represents a top life science-based vendor generating over $30 billion per annum.
The Importance of Immunotherapy
This program, sponsored by Thermo Fisher Scientific, centers on the importance of the development of biomarkers that can help target treatment-ready patients. José Luis Costa, PhD, director of medical affairs for clinical next-generation sequencing and oncology for the company, shared, “The goal of immunotherapy is to provide the immune system with tools to recognize and fight cancers.” He continued, “To ensure more patients may benefit from revolutionary immunotherapy-based drugs, further investigation is needed to validate predicti...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).